^
Association details:
Biomarker:PPARG positive
Cancer:Bladder Cancer
Drug:rosiglitazone (PPAR γ agonist)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: D – Preclinical
Source:
Title:

MP17-12: Identification of FOXA1 as a Master Regulator of PPAR? Action in Bladder Cancer

Published date:
05/15/2020
Excerpt:
...as well as basal 5637 were identified as PPAR? positive and TZD responsive...Luminal UMUC1 and SW780 cells showed a robust response of the PPAR? regulon following TZD and/or inhibitor treatment…